Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study
-
Published:2023-06
Issue:
Volume:60
Page:102010
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Hu Yongxian,
Zu Cheng,
Zhang Mingming,
Wei Guoqing,
Li Wei,
Fu Shan,
Hong Ruimin,
Zhou Linghui,
Wu Wenjun,
Cui Jiazhen,
Wang Dongrui,
Du Bing,
Liu Mingyao,
Zhang Jiqin,
Huang HeORCID
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献